Men over 70 undergoing low-value prostate cancer screening
CANCER DIGEST – Jan. 4, 2023 – An analysis of Medicare data shows that men over 70 may be undergoing unnecessary prostate cancer...
Metastasis-directed therapy may prolong progression-free survival in prostate cancer
CANCER DIGEST – Nov. 12, 2022 – For patients with prostate cancer that has spread to a single site outside the prostate, a therapy...
Adding drug to androgen suppression boosts progression-free survival in prostate cancer
CANCER DIGEST – Nov. 6, 2022 – An investigational therapy increased progression-free survival in 40 percent of nine patients whose...